medicine produced with care, designed for your health

Composition :
Gliclazide 80mg  and Metformin 500mg Tablets.

Indication :
NIDDM patients not controlled with monotherapy in obese patients
  1.     Corrects both defects in such patients.
  2.     Increases insulin secretion.
  3.     Improves insulin sensitivity.
  4.     No Weight gain

Class Of Drug :
Dosage :
1 tablet B.D.
Contraindications :
HYPERSENSITIVITY; TYPE 1 DIABETES MALLITUS; SEVERE RENAL & hepatic impairment; diabetic coma, diabetic ketoacidosis; cardiac failure.
Precautions :
Hypoglycaemia. May require insulins during metabolic stress.
Mechanism Of Action :
Gliclazide Increases insulin secretion and Metformin improves insulin sensitivity also reduces glucose production in the liver thus provides dual benefits because of the complimentary action 
DISCLAIMER : This product is available only in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.